|
- 积分
- 1
- 威望
- 1
- 包包
- 292
|
When Nature broke the news in December 2011 that Novartis
5 x/ w \) S4 ]$ ~: hwas to close its brain research facility in Basel, Switzerland,
5 i# E4 E5 V" N/ w# U. H& @the story noted that this move closely followed similar cuts7 k) F. ?) q, K& Q! ?! l. F
by rival pharmaceutical firms. As a report from the European College/ C% o. ~) M* S
of Neuropsychopharmacology
+ r( c9 R$ H& B8 nhad warned a few months earlier, the- ?+ O) T/ ]: }3 u, ?" ?6 q
abandonment of research into new psychiatric drugs by AstraZeneca,
3 c/ a( `) y o0 aGlaxoSmithKline" c) V; [( e1 k$ S: g/ E# Y1 s
and others meant that “withdrawal of research9 J9 r. L* `3 i/ s: H) n) C
resources is a withdrawal of hope for patients and their families”.
# C- c# N' z) d5 m* f' h6 t1 ]5 z; M: P$ E; K
1 ^) r9 t' A! C$ W( {回复有免费下载链接
- O% X/ }, q- o# S6 W9 C7 l6 a. O) c+ B9 ~0 M# i- ], H
|
-
总评分: 包包 + 20
查看全部评分
|
发表于 2013-10-12 08:22
发表于 2013-10-12 08:44
